Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China; Center for TMD & Orofacial Pain, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China.
Arch Oral Biol. 2017 Oct;82:171-179. doi: 10.1016/j.archoralbio.2017.06.019. Epub 2017 Jun 16.
Our previous study showed that WNT5A, a member of the noncanonical WNT pathway, is involved in interleukin-1beta induced matrix metalloproteinase expression in temporomandibular joint (TMJ) condylar chondrocytes. The purpose of this study is to further explore the roles of WNT5A in cartilage biology of the TMJ.
An early TMJ osteoarthritis-like rat model was constructed by a mechanical method (steady mouth-opening). The gene and protein levels of WNT5A during the condylar cartilage changes were measured. Effects of WNT5A on chondrocyte proliferation, hypertrophy and migration were analyzed after WNT5A gain or loss of function in vitro. A c-Jun N-terminal kinase (JNK) inhibitor SP600125 was used to evaluate the involvement of JNK pathway in these effects of WNT5A. The expression and transcription activity of cell cycle regulators c-MYC and Cyclin D1 were examined to determine the mechanism behind WNT5A regulation of chondrocyte proliferation.
WNT5A was significantly upregulated in the condylar cartilage of rats in the early TMJ osteoarthritis-like model. Activating WNT5A facilitated condylar chondrocyte proliferation, hypertrophy and migration. Conversely, inhibiting WNT5A activity in chondrocytes decreased their proliferation, hypertrophy and migration. Blockage of the JNK pathway by its inhibitor, SP600125, impaired these effects of WNT5A on chondrocytes. WNT5A regulated both the expression and transcriptional activity of c-MYC and Cyclin D1 in chondrocytes, both of which were upregulated in condylar cartilage of the rat early TMJ osteoarthritis.
WNT5A regulates condylar chondrocyte proliferation, hypertrophy and migration. These findings provide new insights into the role of WNT5A signaling in TMJ cartilage biology and its potential in future therapy for TMJ degenerative diseases.
我们之前的研究表明,非经典 WNT 通路成员 WNT5A 参与了白细胞介素-1β诱导的颞下颌关节(TMJ)髁状突软骨细胞中基质金属蛋白酶的表达。本研究旨在进一步探讨 WNT5A 在 TMJ 软骨生物学中的作用。
通过机械方法(稳定张口)构建早期 TMJ 骨关节炎样大鼠模型。测量髁状突软骨变化过程中 WNT5A 的基因和蛋白水平。在体外研究 WNT5A 功能获得或缺失后,分析 WNT5A 对软骨细胞增殖、肥大和迁移的影响。使用 c-Jun N 端激酶(JNK)抑制剂 SP600125 来评估 JNK 通路在 WNT5A 这些作用中的参与情况。检查细胞周期调节因子 c-MYC 和细胞周期蛋白 D1 的表达和转录活性,以确定 WNT5A 调节软骨细胞增殖的机制。
在早期 TMJ 骨关节炎样模型大鼠的髁状突软骨中,WNT5A 明显上调。激活 WNT5A 促进髁状突软骨细胞增殖、肥大和迁移。相反,抑制软骨细胞中的 WNT5A 活性会降低其增殖、肥大和迁移。其抑制剂 SP600125 阻断 JNK 通路会损害 WNT5A 对软骨细胞的这些作用。WNT5A 调节软骨细胞中 c-MYC 和细胞周期蛋白 D1 的表达和转录活性,两者在大鼠早期 TMJ 骨关节炎的髁状突软骨中均上调。
WNT5A 调节髁状突软骨细胞的增殖、肥大和迁移。这些发现为 WNT5A 信号在 TMJ 软骨生物学中的作用及其在未来 TMJ 退行性疾病治疗中的潜力提供了新的见解。